The structured interdisciplinary rounds combined a structured format for communications with a forum for regular interdisciplinary meetings. Researchers assessed the impact of the interdisciplinary rounds on 185 control patients (concurrent control) and 185 intervention patients admitted 24 weeks after the implementation. Researchers also studied 185 patients (historic control) admitted 24 weeks before implementation of the rounds.
Results of their study showed the rate of adverse events was 3.9 per 100 patient days for intervention patients, compared with 7.2 and 7.7 per 100 patient days for concurrent and historic control patients. Similarly, the rate of preventable adverse events was 0.9 per 100 patient days for intervention patients, compared with 2.8 and 2.1 per 100 patient days for concurrent and historic control patients.
Read the study about structured interdisciplinary rounds.
Read other coverage about adverse events:
– Study: Hospital Errors Occurring 10 Times More Than Previously Detected
– CMS Proposes Rule on Payment Adjustment for Provider-Preventable Conditions
– Patient Deaths More Likely When Nurses Report Long Hours
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
